A Randomized Comparison of Rifaximin Versus Lactulose in Hospitalized Cirrhotic Patients With Renal Failure

NCT02086825 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Conditions

Hepatic Encephalopathy

Interventions

DRUG: Rifaximin
DRUG: Lactulose

Sponsor

NYU Langone Health